Biocartis In Brief This Week: Burning Rock Biotech, Biocartis, NYGC, Eagle Genomics, Theradiag, OpGen, More News items for the week of Jan. 16, 2023. Biocartis Reports 14 Percent Increase in Q3 Product Revenue The Mechelen, Belgium-based molecular diagnostics developer said it has placed 189 new instruments to date this year. Ophiomics Liver Cancer Assay Gets CE-IVD Mark Biocartis is launching the HepatoPredict gene expression assay to help predict the benefits of liver transplant in hepatocellular carcinoma patients. SkylineDx Gains CE-IVD Mark for Melanoma Metastasis Risk Assay The Netherlands-based firm is partnering with Belgian company Biocartis on European commercialization of the qPCR assay, which could reduce unnecessary surgeries. Biocartis Posts 21 Percent Jump in H1 Revenues The company also announced a recapitalization that is expected to provide it with roughly €66 million in new capital. Aug 26, 2022 In Brief This Week: Genetron, MDxHealth, Biocept, Beckman Coulter, Biocartis, Satio, More Jun 22, 2022 Biocartis, AstraZeneca Ink Companion Diagnostic Pact Jun 20, 2022 Biocartis Nabs CE Mark for Lung Cancer Test Apr 22, 2022 In Brief This Week: Biocartis, Co-Diagnostics, Blueprint Medicines, Celogics, More Mar 4, 2022 Biocartis, Ophiomics Collaborate on Liver Transplant Test With Eye on Development for MDx Platform Premium Feb 24, 2022 Biocartis Reports 12 Percent Rise in 2021 Revenues Jan 14, 2022 In Brief This Week: BGI, Gencove, Cepheid, Biocartis, Biognosys, Co-Diagnostics, More Nov 30, 2021 Immunexpress Receives FDA 510(k) Clearance for Sepsis Assay Sep 2, 2021 Biocartis H1 Revenues up 31 Percent May 11, 2021 Biocartis Receives €1.4M Grant to Develop New Technology for Molecular Surveillance Apr 22, 2021 Biocartis, SkylineDx Partner to Develop Melanoma Nodal Metastasis Risk Test Apr 20, 2021 Biocartis Files FDA Submission for Microsatellite Instability Test in Colorectal Cancer Mar 26, 2021 New Products Posted to GenomeWeb: Caris Life Sciences, Qlucore, Biocartis, More Feb 25, 2021 Biocartis Reports 15 Percent Rise in 2020 Revenues Nov 12, 2020 Biocartis Q3 Cartridge Volume Grows 61 Percent Nov 10, 2020 Biocartis Gets CE Mark for SARS-CoV-2 RT-PCR Test Nov 4, 2020 Biocartis to Invest in IVD Partnerships Following Termination of Genomic Health Deal Premium Nov 3, 2020 Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform Oct 29, 2020 Biocartis, Exact Sciences Terminate Oncotype DX Agreement Sep 30, 2020 Biocartis Receives €1.2M Flemish Government Grant to Develop GeneFusion Assay on Idylla Platform Load More Breaking News Simple HealthKit Raises $8M in Series A Round Top Five Articles on GenomeWeb Last Week: Quantum-Si Layoffs, UBS Coverage Initiations, More LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test Rarity Bioscience Raises Additional €500,000 Cancer Prognoses Informed by Module-Based Approach, Study Finds The Scan UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers. DNA Biobank Developed for French Kidney Donors, Recipients The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France. Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site. Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.